羟基积雪草苷对小鼠抑郁行为和大鼠不同脑区单胺氧化酶活性的影响

doi:10.3736/jcim20040611

Abstract

Objective: To evaluate the effects of madecassoside (MC) on the depression behavior of mice and the activities of monoamine oxidase (MAO) in different rat brain regions.Methods: Imipramine as the positive contrast medicine, effects of MC on the depression behavior of mice were observed by forced swimming test and reserpine antagonist test. Moclobemide and pargyline as the positive controlled medicines, the activities of monoamine oxidase-A (MAO-A) and monoamine oxidase-B (MAO-B) in different rat brain regions were determined after intragastric administration of MC in 3 different dosages for 3 days or 21 days.Results: (1) The low, middle and high dosages of MC (i.g.) significantly reduced the immobility time of mice in forced swimming test (P<0.05). (2) MC in dosages of 10 mg/kg and 20 mg/kg prevented the lowering of temperature induced by reserpine (P<0.05), while 40 mg/kg had no significant effects on it (P>0.05). (3) With acute administration (3 days), the low, middle and high dosagey of MC (i.g.) significantly inhibited the activity of MAO-A in hippocampus (P<0.01), and the high dosage significantly inhibited the activity of MAO-A in hypothalamus (P<0.01), while the 3 dosages had no significant effects on the activity of MAO-A in cortex (P>0.05). With chronic administration (21 days), MC in 3 dosages had no significant effects on the activities of MAO-A in cortex and hypothalamus (P>0.05), and the high dosage (40 mg/kg) significantly enhanced the activity of MAO-A in hippocampus (P<0.01). (4) With acute administration, MC in dosages of 10 mg/kg and 20 mg/kg significantly inhibited the activity of MAO-B in cortex (P<0.05), and MC in dosage of 10 mg/kg significantly inhibited the activity of MAO-B in hypothalamus (P<0.05), and MC in dosage of 20 mg/kg significantly enhanced the activity of MAO-B in hippocampus (P<0.01). With chronic administration, MC of 3 dosages produced no significant effects on the activities of MAO-B in 3 different rat brain regions (P>0.05).Conclusion: These results support the idea that MC produces antidepressant effects through MAO inhibition in rat brain, which seems stronger with acute administration than chronic administration, while its mechanism remains to be further studied.

Key words: madecassoside, depression, monoamine oxidase, animals, laboratory

CLC Number:

R285.5

Mu-rong Liu, Ting Han, Yao Chen, Lu-ping Qin, Han-chen Zheng, Yao-cheng Rui. Effect of madecassoside on depression behavior of mice and activities of MAO in different brain regions of rats. Journal of Chinese Integrative Medicine, 2004, 2(6): 440-444.

/ / Recommend

Add to citation manager EndNote| Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.jcimjournal.com/EN/10.3736/jcim20040611

http://www.jcimjournal.com/EN/Y2004/V2/I6/440

TrendMD

Figures/Tables 6

Tab 1

Tab 2

Tab 3

Tab 4

Tab 5

Tab 6

References 14

[1]	秦路平, 郑汉臣, 丁如贤 , 等. 中药积雪草原植物的本草考证[J]. 中国野生植物资源, 1997,16(1):19-21
[2]	张中启, 袁莉, 罗质璞 . 积雪草提取物抑制小鼠体外脑单胺氧化酶A的活性[J]. 军事医学科学院院刊, 2000,24(2):158 doi: 10.3969/j.issn.1674-9960.2000.02.026
[3]	陈瑶, 秦路平, 芮耀诚 , 等. 积雪草提取物抗抑郁作用实验研究[J]. 中国药理学会通讯, 2002,19(1):70
[4]	张均田 . 现代药理实验方法学(第1版)[M]. 北京: 北京医科大学中国协和医科大学联合出版社, 1998,( 第1版):1062
[5]	赵维中, 章家胜, 明亮 , 等. 国产吗氯贝胺的抗抑郁作用[J]. 中国药理学通报, 1995,11(5):395-397
[6]	吕宝璋, 卢建, 安明榜 .受体学 ( 第1版)[M]. 合肥: 安徽科学技术出版社, 2000,( 第1版):355
[7]	Robinson DS . Monoamine oxidase inhibitors: a new generation[J]. Psychopharmacol Bull, 2002,36(3):124-138
[8]	Du L, Faludi G, Palkovits M , et al. High activity-related allele of MAO-A gene associated with depressed suicide in males[J]. Neuroreport, 2002,13(9):1195-1198 doi: 10.1097/00001756-200207020-00025
[9]	Bonnet U . Moclobemide: therapeutic use and clinical studies[J]. CNS Drug Rev, 2003,9(1):97-140 doi: 10.1111/j.1527-3458.2003.tb00245.x pmid: 12595913
[10]	郑莉, 刘国卿 . 贯叶连翘提取物对单胺氧化酶与单胺递质的影响[J]. 中国药科大学学报, 2002,33(2):138-141 doi: 10.3321/j.issn:1000-5048.2002.02.016
[11]	Wells DG, Bjorksten AR . Monoamine oxidase inhibitors revisited[J]. Can J Anaesth, 1989,36(1):64-74 doi: 10.1007/BF03010890
[13]	Da Prada M, Kettler R, Keller HH , et al. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A[J]. J Pharmacol Exp Ther, 1989,248(1):400-414
[14]	Panova NG, Axenova LN, Medvedev AE . The stimulating effects of ethanol consumption on synjournal of rat brain monoamine oxidases and their sensitivity to the irreversible inhibitor, pargyline[J]. Neurosci Lett, 2000,292(1):66-68 doi: 10.1016/S0304-3940(00)01439-7

Related Articles 15

[1]	Mary Abiola Okesola, Basiru Olaitan Ajiboye, Babatunji Emmanuel Oyinloye, Oluwafemi Adeleke Ojo. Neuromodulatory effects of ethyl acetate fraction of Zingiber officinale Roscoe extract in rats with lead-induced oxidative stress. Journal of Integrative Medicine, 2019, 17(2): 125-131.
[2]	Bosch Peggy, van den Noort Maurits, Yeo Sujung, Lim Sabina, Coenen Anton, van Luijtelaar Gilles. The effect of acupuncture on mood and working memory in patients with depression and schizophrenia. Journal of Integrative Medicine, 2015, 13(6): 380-390.
[3]	Sheng Wei, Jin-liang Hou, Yu-bin Chao, Xi-yang Du, Shao-bo Zong . Analysis on content of serum monoamine neurotransmitters in macaques with anger-in-induced premenstrual syndrome and liver-qi depression syndrome. Journal of Chinese Integrative Medicine, 2012, 10(8): 925-931.
[4]	Li Xiao-hong, Li Jing-jing, Liu Yue-yun, Chen Jia-xu. Central neurobiological mechanism of liver depression and spleen deficiency syndrome based on chronic stress: a review. Journal of Chinese Integrative Medicine, 2012, 10(1): 1-6.
[5]	Sui Yue Hu, Su E Wang, Chun Hu Zhang. Relationship between symptom stratification and syndrome differentiation of traditional Chinese medicine for depressive episode. Journal of Chinese Integrative Medicine, 2011, 9(9): 933-936.
[6]	Cai Lin-lin, Li Hao, Liu Jian-gang, Liu Long-tao, Guan Jie, Liu Ming-fang, Hu Jia, Wei Yun. Effects of early intervention with Huannao Yicong formula effective components on behavior and cholinergic system of β-amyloid precursor protein transgenic mice. Journal of Chinese Integrative Medicine, 2011, 9(3): 292-298.
[7]	Hui Han, Li-min Wu, Wen-ming Yang, Mei-xia Wang, Jing-jing Tang, Han Wang, Zhi-xiu Liu, Rong-zhi Liu, Ting Dong, Juan Zhang , Bo Yang, Ming-xiang Han. Characteristics of traditional Chinese medicine syndromes in post-stroke depression. Journal of Chinese Integrative Medicine, 2010, 8(5): 427-431.
[8]	Li-juan Xiu, Pin-kang Wei, Hui-ming Lin, Bin Pang. Effects of Xiaotan Jieyu Recipe on behaviors of tumor-bearing rats with chronic mild stress and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(2): 138-144.
[9]	Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017.
[10]	Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079.
[11]	Xing-juan Wang, Ji Li, Qin-di Zou, Ling Jin. Wuling Capsule for climacteric patients with depression and anxiety state: A randomized, positive parallel controlled trial. Journal of Chinese Integrative Medicine, 2009, 7(11): 1042-1046.
[12]	Yun-hui Li, Chun-hu Zhang, Su-e Wang, Juan Qiu, Sui-yu Hu, Gui-lin Xiao. Effects of Chaihu Shugan San on behavior and plasma levels of corticotropin releasing hormone and adrenocorticotropic hormone of rats with chronic mild unpredicted stress depression. Journal of Chinese Integrative Medicine, 2009, 7(11): 1073-1077.
[13]	Qiao-ge Chen, Yuan-shan Zeng, Jiu-yu Tang, Ya-jing Qin, Sui-jun Chen, Zhi-qiang Zhong. Effects of Rhodiola rosea on body weight and intake of sucrose and water in depressive rats induced by chronic mild stress. Journal of Chinese Integrative Medicine, 2008, 6(9): 952-955.
[14]	Yong-jun Wang, Qi Shi, Jian-chun Jiang, Qian-qian Liang, Qin Bian, Chen-guang Li, Quan Zhou, Xue-jun Cui, Min Huang, Qing-gao Liu, Sheng Lu, Chong-jian Zhou. Establishment of a rat model of cervical syndrome with qi deficiency, blood stasis and kidney deficiency. Journal of Chinese Integrative Medicine, 2008, 6(11): 1152-1158.
[15]	Qi Li, Zhong-ze Fan, Xian-qian Li, Xiao-hua Liu, Jue Sun, Wei Gu, Paul Heng, Hong Gao. Effects of interventional therapy with norcantharidin microsphere on hepatoma in rats and its mechanism. Journal of Chinese Integrative Medicine, 2006, 4(4): 378-383.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[2]	Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[3]	Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[4]	You-hua Wang , Shang Li , Bin-rui Yang , Lun-qing Zhang , Xin Zhou , Bei-wen Xu, Ming-yuan Li . Use of zebrafish models for the research of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1189-1197
[5]	Dong-tao Li, Jian Wang , Hong-yang Jiang , Feng-lei Shi , Fu-yu Li , Ji-hong Liu , Yong-mei Cheng , Nan Yan , Ai-hua Hu, Mei-zeng Zhang , Jie Li, Ling-bo Wei , Rong-qin Jiang. Quantitative evaluation of the degrees of traditional Chinese medicine qualitative syndromes of osteoporosis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1254-1262
[6]	Yuan-jie Wu , Zhao-hui Fang , Shu-guo Zheng , Yuan-bo Wu , Ai-hua Fan. Effects of Chinese herbal medicine Danzhi Jiangtang Capsule and exercise on JNK signaling pathway in pancreatic tissues of diabetic rats. Journal of Chinese Integrative Medicine, 2012, 10(11): 1279-1285
[7]	Samadder Asmita, Das Jayeeta, Das Sreemanti, Biswas Raktim, Rahman Khuda-Bukhsh Anisur. Ameliorative potentials of Syzygium jambolanum extract against arsenic-induced stress in L6 cells in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1293-1302
[8]	Zhao-guo Li , Rui-qiang Liu. Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine: Diseases in Internal Medicine (Part 7). Journal of Chinese Integrative Medicine, 2012, 10(11): 1310-1315
[9]	Peng-fei Gao, Kenji Watanabe. Introduction of the World Health Organization project of the International Classification of Traditional Medicine. Journal of Chinese Integrative Medicine, 2011, 9(11): 1161-1164
[10]	Kishan Lal Tiwari, Shailesh Kumar Jadhav, Veenu Joshi. An updated review on medicinal herb genus Spilanthes. Journal of Chinese Integrative Medicine, 2011, 9(11): 1170-1178

Group	n	Immobility time （s）
Untreated	10	90.7±22.0
Imipramine (20 mg/kg)	10	30.0±23.6**
Low dosage of MC (10 mg/kg)	10	47.7±24.6**
Middle dosage of MC (20 mg/kg)	10	49.0±17.2**
High dosage of MC (40 mg/kg)	10	38.3±17.0**

Group	n	Temperature （℃）
Normal control	10	37.73±0.15
Model control	10	37.29±0.21
Imipramine (20 mg/kg)	10	37.70±0.28*
Low dosage of MC (10 mg/kg)	10	37.60±0.10*
Middle dosage of MC (20 mg/kg)	10	37.63±0.18*
High dosage of MC (40 mg/kg)	10	37.57±0.12

Group	n	Activity of MAO-A (U·h-1·mg-1)
Group	n	Cortex	Hippocampus	Hypothalamus
Untreated	8	425.4±10.3	451.7±11.5	433.7±5.8
Moclobemide (12 mg/kg)	8	426.9±6.0	427.2±8.0**	416.6±4.0**
Low dosage of MC (10 mg/kg)	8	425.6±8.7	428.9±7.3**	435.5±8.4^△△
Middle dosage of MC (20 mg/kg)	8	420.9±7.7	419.2±6.4**	425.1±9.3*^△
High dosage of MC (40 mg/kg)	8	419.7±4.7^△	424.9±10.1**	421.3±7.8**

Group	n	Activity of MAO-A (U·h-1·mg-1)
Group	n	Cortex	Hippocampus	Hypothalamus
Untreated	8	430.9±7.1	423.8±5.9	423.2±7.5
Moclobemide (12 mg/kg)	8	429.2±6.3	433.3±5.4**	423.1±7.3
Low dosage of MC (10 mg/kg)	8	432.5±8.3	427.9±4.9	426.5±9.2
Middle dosage of MC (20 mg/kg)	8	428.3±8.8	426.3±4.7^△	425.3±7.9
High dosage of MC (40 mg/kg)	8	428.6±9.0	437.3±7.5**	423.6±7.4

Group	n	Activity of MAO-B (U·h-1·mg-1)
Group	n	Cortex	Hippocampus	Hypothalamus
Untreated	8	14.4±1.5	18.4±1.0	25.9±2.0
Pargyline (10 mg/kg)	8	10.7±1.2**	16.4±0.7*	21.4±1.1*
Low dosage of MC (10 mg/kg)	8	9.5±2.8*	22.0±3.3^△	21.9±2.1*
Middle doage of MC (20 mg/kg)	8	10.4±2.1*	24.6±3.0**^△△	23.4±2.5
High doage of MC (40 mg/kg)	8	17.7±2.3*^△△	19.2±2.5	27.8±3.5^△

Effect of madecassoside on depression behavior of mice and activities of MAO in different brain regions of rats

RichHTML

PDF (PC)

Like